🇺🇸 FDA
Pipeline program

Favipiravir

2020 research 112

Unknown small_molecule active

Quick answer

Favipiravir for COVID-19 is a Unknown program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
COVID-19
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials